Wild North American hemp is derived mostly from escaped European cultivated hemp imported in past centuries, perhaps especially from a revival of cultivation during World War II. Wild Canadian hemp is concentrated along the St. Lawrence and lower Great Lakes, where considerable cultivation occurred in the 1800s. In the US, wild hemp is best established in the American Midwest and Northeast, where hemp was grown historically in large amounts. Decades of eradication have exterminated many of the naturalized populations in North America. In the US, wild plants are rather contemptuously called “ditch weed” by law enforcement personnel. However, the attempts to destroy the wild populations are short-sighted, because they are a natural genetic reservoir, mostly low in THC. Wild North American plants have undergone many generations of natural adaptation to local conditions of climate, soil and pests, and accordingly it is safe to conclude that they harbor genes that are invaluable for the improvement of hemp cultivars. We have encountered exceptionally vigorous wild Canadian plants (Fig. 52), and grown wild plants from Europe (Fig. 53) which could prove valuable. Indeed, studies are in progress in Ontario to evaluate the agronomic usefulness of wild North American hemp. Nevertheless, present policies in North America require the eradication of wild hemp wherever encountered. In Europe and Asia, there is little concern about wild hemp, which remains a valuable resource.
The environment in which hemp and marijuana are grown is strikingly different. Hemp is grown closely together (as close as 4 inches apart) and are typically grown in large multi-acre plots. It can also grow in variety of climates and its growth cycle is 108-120 days. Unlike hemp, marijuana requires a carefully controlled, warm, and humid atmostphere for proper growth. Its growth cycle only 60-90 days. Medical cannabis also cannot be grown too close to each other. They are typically grown 6 feet apart. If, somehow, marijuana grows among (or close to) a hemp field, the hemp’s pollen would immediateately ruin the marijuana crop, diluting marijuana’s psychoactivity.
Several of the cannabinoids are reputed to have medicinal potential: THC for glaucoma, spasticity from spinal injury or multiple sclerosis, pain, inflammation, insomnia, and asthma; CBD for some psychological problems. The Netherlands firm HortaPharm developed strains of Cannabis rich in particular cannabinoids. The British firm G.W. Pharmaceuticals acquired proprietary access to these for medicinal purposes, and is developing medicinal marijuana. In the US, NIH (National Institute of Health) has a program of research into medicinal marijuana, and has supplied a handful of individuals for years with maintenance samples for medical usage. The American Drug Enforcement Administration is hostile to the medicinal use of Cannabis, and for decades research on medicinal properties of Cannabis in the US has been in an extremely inhospitable climate, except for projects and researchers concerned with curbing drug abuse. Synthetic preparations of THC—dronabinol (Marinol®) and nabilone (Cesamet®)—are permitted in some cases, but are expensive and widely considered to be less effective than simply smoking preparations of marijuana. Relatively little material needs to be cultivated for medicinal purposes (Small 1971), although security considerations considerably inflate costs. The potential as a “new crop” for medicinal cannabinoid uses is therefore limited. However, the added-value potential in the form of proprietary drug derivatives and drug-delivery systems is huge. The medicinal efficacy of Cannabis is extremely controversial, and regrettably is often confounded with the issue of balancing harm and liberty concerning the proscriptions against recreational use of marijuana. This paper is principally concerned with the industrial uses of Cannabis. In this context, the chief significance of medicinal Cannabis is that, like the issue of recreational use, it has made it very difficult to rationally consider the development of industrial hemp in North America for purposes that everyone should agree are not harmful.
Since Cannabis smoke contains many of the same components as tobacco smoke, there are valid concerns about the adverse pulmonary effects of inhaled Cannabis. A longitudinal study in a noncancer population evaluated repeated measurements of pulmonary function over 20 years in 5,115 men and women whose smoking histories were known.[5] While tobacco exposure was associated with decreased pulmonary function, the investigators concluded that occasional and low-cumulative Cannabis use was not associated with adverse effects on pulmonary function (forced expiratory volume in the first second of expiration [FEV1] and forced vital capacity [FVC]).
Industrial hemp is marketed a fiber, as a seed, or as a dual-purpose crop. Although detailed market information for hemp ins not readily available, estimates from Vote Hemp show that the total retail value of hemp products in the U.S. in 2017 was $820 million. This includes food and body products, clothing, auto parts, building materials, and other products.
Hemp was made illegal to grow without a permit in the U.S. under the Controlled Substances Act passed in 1970 because of its relation to marijuana,[17] and any imported hemp products must meet a zero tolerance level.[87] Some states have made the cultivation of industrial hemp legal, but farmers in many states have not yet begun to grow it because of resistance from the federal Drug Enforcement Administration,[88] making "large-scale hemp growing" in the United States "not viable" as late as 2013.[89] In 2013, after the legalization of cannabis in the state, several farmers in Colorado planted and harvested several acres of hemp, bringing in the first hemp crop in the United States in over half a century.[90] Colorado,[91] Vermont, California, and North Dakota have passed laws enabling hemp licensure. All four states are waiting for permission to grow hemp from the DEA. Currently,[92] Oregon has licensed industrial hemp as of August 2009.[93] Congress included a provision in the Agricultural Act of 2014 that allowed colleges and state agencies to grow and conduct research on hemp in states where it is legal.[17] Hemp production in Kentucky, formerly the United States' leading producer, resumed in 2014.[94] Hemp production in North Carolina resumed in 2017,[95] and in Washington State the same year.[96] By the end of 2017, at least 34 U.S. states had industrial hemp programs.[97] In 2018, New York began taking strides in industrial hemp production, along with hemp research pilot programs at Cornell University, Binghamton University and SUNY Morrisville.[98]
“Hemp is of high nutritional quality because it contains high amounts of unsaturated fatty acids… Linoleic acid and alpha-linolenic acid are the only two fatty acids that must be ingested and are considered essential to human health … In contrast to shorter-chain and more saturated fatty acids, these essential fatty acids do not serve as energy sources, but as raw materials for cell structure and as precursors for biosynthesis for many of the body’s regulatory biochemicals…”  

Best CBD Oil